Cory Littlepage, an enrolled member of Chickasaw Nation, founded Tribal Diagnostics in October 2015. As the Chief Executive Officer, he is responsible for the strategic growth and operations of the company. He has two decades of experience in the healthcare field. Beginning his healthcare career at Pfizer, Mr. Littlepage quickly rose through the ranks of multiple departments. Prior to founding Tribal Diagnostics, he worked for a private equity portfolio company, Expert Global Solutions, performing merger integration work. Due to his performance, he was promoted to lead EGS’ largest healthcare account, effectively coordinating the efforts of 2,400 EGS colleagues across 10 international locations. Mr. Littlepage holds a bachelor’s degree in Business Administration from the University of Kansas and a master’s degree in Finance from Southern Methodist University.

Dr. Shalini Muralidhar is the Chief Laboratory Officer for Tribal Diagnostics where she is responsible for the overall operation and administration of the laboratory.

Shalini Muralidhar Ph.D. has 16+ years of experience working in the Clinical diagnostic and laboratory industry. She has led team of professionals with a focus on quality, efficiency, and excellence. Before joining Tribal as Chief Laboratory Officer, she has served leadership roles at Advanta Genetics, Everlywell Diagnostics and most recently as Senior Laboratory Director for HealthTrackRx. Dr. Muralidhar has years of experience in all aspects of laboratory including quality management, credentialing, budgeting, and clinical laboratory operations. She has successfully built start-ups and scaled high-volume clinical laboratories.

Dr. Muralidhar obtained her Ph.D. in Molecular and Cell Biology from the University of Texas at Dallas. As ABB (American Board of Bioanalysis) board-certified High Complexity Laboratory Director (HCLD), she has served as CLIA Laboratory Director for multiple laboratories specialized in Molecular, hematology, microbiology, immunology, genetics, toxicology, hematology, chemistry, -home collection and direct to consumer testing. In 2018, she received Certification of Qualification (CoQ) from Clinical Laboratory Evaluation Program (CLEP) to serve as a Director for molecular testing facilities that have a New York State Department of Health clinical laboratory permit. Dr. Muralidhar has technical expertise in method development and new product validations for patient testing as per CLIA, COLA, CAP, NY and CA state standards. She has a strong understanding of regulatory and compliance needs and recently received recognition as “2023 Inspection Excellence” from the CAP (College of American Pathology) Accreditation program.

Jen Bartlett, PHR is the Human Resources Director for Tribal Diagnostics and is responsible for Tribal’s People Strategy.  Key focus areas include colleague engagement, talent acquisition, compensation & benefits.  Prior to joining Tribal Diagnostics in 2021, Jen held various HR leadership positions in communications, healthcare, consulting and legal industries.

Jen graduated from the University of Central Oklahoma in Edmond with a General Studies degree.  She also holds an MBA from the University of Phoenix and has had her PHR certification since 2003.  She currently lives in Oklahoma City.

Bailey Walker is an enrolled member of Chickasaw Nation and brings a background of 20 years working in Indian Country. Mr. Walker previously served as the preferred vendor program coordinator for the Chickasaw Nation where he advocated on behalf of vendors aspiring to do business with the Chickasaw Nation and other tribal nations across Indian Country.

Mr. Walker is the current president of the American Indian Chamber of Commerce of Oklahoma where he was instrumental in creating several chapters across the state and helped build the Leadership Native Oklahoma program to assist future leaders in tribal governments and sovereignty.

Mr. Walker has a degree in Entrepreneurship from East Central University and is an accredited and certified Master Business Consultant. Mr. Walker was recognized as the 2017 “Advocate of the Year” by the U.S. Department of Commerce – Minority Enterprise Development division.

April Hale, a citizen of the Navajo Nation from Iyanbito, New Mexico, is the Owner/President of A. Hale PR, Inc., a Navajo woman-owned public relations company based in Albuquerque, New Mexico. Ms. Hale returned to New Mexico from Washington, DC where she worked for 11 years with national tribal non-profit organizations. Most recently, Ms. Hale served as the Communication Specialist for the Notah Begay III (NB3) Foundation where she oversaw all external communications, managed media and promoted Native youth campaigns targeting healthy weight, increased water intake and physical activity and decreased sugary drink consumption.

While in Washington, DC, Ms. Hale was a Public Affairs Specialist with the Indian Health Service (IHS) where she served as the lead speech writer for the director and covered tribal health reform and quality improvement issues. Prior to working with IHS, Ms. Hale served as the is the Tribal Health Care Reform Outreach and Education Communications Coordinator at the National Indian Health Board (NIHB), where she worked on the National Indian Health Outreach and Education initiative.

Before joining the NIHB team, Ms. Hale did communications and legislative work for the National American Indian Housing Council and the National Congress of American Indians. Ms. Hale has a certificate in Communications and Advocacy from Capitol Net, a Bachelor’s degree in Journalism from the University of New Mexico and is a 2002 graduate of the Freedom Forum Diversity Institute’s American Indian Journalism Institute at the University of South Dakota.

Mr. Fleming holds a B.S. in Forensic Science with a concentration in Forensic Chemistry as well as a M.S. in Forensic Toxicology. Mr. Fleming is board certified as a Fellow of American Board of Forensic Toxicology, a Toxicological Chemist by National Registry of Certified Chemists, and holds a California Clinical Toxicologist Scientist License.  He has a demonstrated history of over 16 years in various roles within clinical chemistry/toxicology laboratories. Upon graduation he was trained at Children’s Mercy Hospital in Kansas City, MO.  Thereafter, he served as a Technical Consultant, Technical Supervisor, Toxicologist, and Director of Research & Development at various clinical laboratories.

Mr. Fleming is very active within the field of toxicology and holds membership in many professional organizations where he is able to keep current with continuing education, drug trends, and analytical technology advances.  Additionally, he has presented research at local, regional and national scientific conferences.  Lastly, he has published many manuscripts in analytical and clinical toxicology medical journals as well as a chapter in Clinical Applications of Mass Spectrometry.

Yanzheng Zhang, MD, is a board-certified Pathologist who specializes in Clinical Pathology. In practice since 2012, he formerly served as a Clinical Pathologist and Associate Director of Transfusion Service at Geisinger Health System in Pennsylvania. Currently he is the CLIA director and clinical consultant for several medical laboratories in Texas and Louisiana.

Dr. Zhang had his medical residency in clinical pathology at UT Southwestern Medical Center during 2007-2010, a transfusion medicine pathology fellowship at Washington University in St. Louis in 2010-2011. He has published widely in the leading pathology and immunology journals and has authored book chapters in human immunology.

Outside of work, Dr. Zhang’s interests include fine arts, sports, and travel.